H. S. Semiz Et Al. , "IS THERE A DIFFERENCE BETWEEN PATIENTS UNDER 65 AND PATIENTS AGE 65 AND OVER IN THE EFFECT AND SAFETY OF CDK 4/6 INHIBITOR + ENDOCRINE THERAPY?," İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.26, no.4, pp.372-378, 2022
Semiz, H. S. Et Al. 2022. IS THERE A DIFFERENCE BETWEEN PATIENTS UNDER 65 AND PATIENTS AGE 65 AND OVER IN THE EFFECT AND SAFETY OF CDK 4/6 INHIBITOR + ENDOCRINE THERAPY?. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.26, no.4 , 372-378.
Semiz, H. S., Keskinkılıç, M., & Yavuzşen, T., (2022). IS THERE A DIFFERENCE BETWEEN PATIENTS UNDER 65 AND PATIENTS AGE 65 AND OVER IN THE EFFECT AND SAFETY OF CDK 4/6 INHIBITOR + ENDOCRINE THERAPY?. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.26, no.4, 372-378.
Semiz, HÜSEYİN, MERVE KESKİNKILIÇ, And TUĞBA YAVUZŞEN. "IS THERE A DIFFERENCE BETWEEN PATIENTS UNDER 65 AND PATIENTS AGE 65 AND OVER IN THE EFFECT AND SAFETY OF CDK 4/6 INHIBITOR + ENDOCRINE THERAPY?," İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.26, no.4, 372-378, 2022
Semiz, HÜSEYİN S. Et Al. "IS THERE A DIFFERENCE BETWEEN PATIENTS UNDER 65 AND PATIENTS AGE 65 AND OVER IN THE EFFECT AND SAFETY OF CDK 4/6 INHIBITOR + ENDOCRINE THERAPY?." İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.26, no.4, pp.372-378, 2022
Semiz, H. S. Keskinkılıç, M. And Yavuzşen, T. (2022) . "IS THERE A DIFFERENCE BETWEEN PATIENTS UNDER 65 AND PATIENTS AGE 65 AND OVER IN THE EFFECT AND SAFETY OF CDK 4/6 INHIBITOR + ENDOCRINE THERAPY?." İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.26, no.4, pp.372-378.
@article{article, author={HÜSEYİN SALİH SEMİZ Et Al. }, title={IS THERE A DIFFERENCE BETWEEN PATIENTS UNDER 65 AND PATIENTS AGE 65 AND OVER IN THE EFFECT AND SAFETY OF CDK 4/6 INHIBITOR + ENDOCRINE THERAPY?}, journal={İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi}, year=2022, pages={372-378} }